NEW YORK (GenomeWeb News) – The US Department of Defense has awarded BioFire Diagnostics, formerly called Idaho Technology, a contract for up to $27.4 million.
In an announcement last week, the Defense Logistics Agency of DOD said the award is a modification on the second option year of a previously awarded contract and is a firm fixed-price, sole-source, indefinite delivery and indefinite quantity contract for reagents, extraction, and inhibition kits.
The military services that may use the kit are the Army, Navy, Air Force, Marine Corps, and federal civilian agencies, DLA said. The date of performance completion is Aug. 31, 2013.
Salt Lake City-based BioFire declined to provide further details about the contract.